Should I buy Vestis (VSTS) stock or is it too late?
⭐ The most reliable of them, either direction: Baird — 57% of its targets hit on this sector (136 calls tested). It aims for $16 (+26 %), call made on August 13, 2026, maturing on August 13, 2027 (15 d ago).
Firm-by-firm track record on Vestis
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Barclays | 83 % | +16.8 % | 6 | $11 -14% |
✅ Reasons to believe
- Few solid positives from analysts right now: of 6 ratings, only 1 buys, and the median price target ($13) is barely above the price (+2%, at $13). Caution prevails.
⚠️ Reasons to hesitate
- Even the most reliable firm on VSTS, Barclays (83% hit rate, 6 scored calls), only targets $11 (call made on August 13, 2026, maturing on August 13, 2027) (-14%) in its most recent call, and $9 (call made on May 15, 2026, maturing on May 15, 2027) (-29%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 6 ratings, 2 are neutral and 3 are sells.
- Limited upside: the median target is only +2% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on VSTS
Median target $13 (+2%) · 6 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Vestis now?
We won't decide for you. The facts: 17% of analysts rate it a buy, median target $13 (+2%), and Barclays (most reliable on VSTS, 83%) targets $11. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Vestis?
The stated upside is small: the median target ($13) sits just +2% from the price ($13) (most reliable on VSTS: Barclays, 83%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Vestis still worth investing in?
It depends on the gap between the price ($13) and its estimated value: analysts target $13 on median (+2%), with 17% buys (most reliable on VSTS: Barclays, 83%). Cross-check with their real reliability on VSTS and the cautions above. Information, not advice.
What's the main risk in buying VSTS?
Even the most reliable firm on VSTS, Barclays (83% hit rate, 6 scored calls), only targets $11 (call made on August 13, 2026, maturing on August 13, 2027) (-14%) in its most recent call, and $9 (call made on May 15, 2026, maturing on May 15, 2027) (-29%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Vestis profile (consensus, analyst reliability, price target, performance).